Abstract
Background: Results of several studies suggest that serum amino acids monitoring in migraine might be useful as an objective measurement of the disease status.
Objective: The aim of the present work was to analyze the profile of aliphatic and aromatic amino acids in blood serum of migraine patients without and with aura between attacks.
Methods: A total number of 37 migraine patients (26 with migraine without aura and 11 with migraine with aura), mean age 39±12 years, and 40 age-matched healthy subjects as the control group, mean age 38±14 years, were included into the study. The levels of glutamic acid, glutamine, histidine (His), valine (Val), isoleucine, leucine (Leu), phenyloalanine, lysine were evaluated.
Results: The level of His was significantly higher in both groups of migraine patients (without and with aura) compared to the control group (F(2,74)=10.17, p=0.00). The levels of Val and Leu were significantly different in migraine without but not with aura, when compared with the control group (F(2,74)=4.70, p=0.01 and F(2,74)=4.39, p=0.02, respectively).
Conclusion: We found higher level of His in migraine patients without and with aura and lower level of Val and Leu in patients with migraine without aura.
Keywords: Amino acids, cortical spreading depression, migraine, neuronal pathogenesis.
CNS & Neurological Disorders - Drug Targets
Title:Changes in Serum Amino Acids in Migraine Patients without and with Aura and their Possible Usefulness in the Study of Migraine Pathogenesis
Volume: 14 Issue: 3
Author(s): Izabela Domitrz, Marek D. Koter, Malgorzata Cholojczyk, Wojciech Domitrz, Anna Baranczyk-Kuzma and Anna Kaminska
Affiliation:
Keywords: Amino acids, cortical spreading depression, migraine, neuronal pathogenesis.
Abstract: Background: Results of several studies suggest that serum amino acids monitoring in migraine might be useful as an objective measurement of the disease status.
Objective: The aim of the present work was to analyze the profile of aliphatic and aromatic amino acids in blood serum of migraine patients without and with aura between attacks.
Methods: A total number of 37 migraine patients (26 with migraine without aura and 11 with migraine with aura), mean age 39±12 years, and 40 age-matched healthy subjects as the control group, mean age 38±14 years, were included into the study. The levels of glutamic acid, glutamine, histidine (His), valine (Val), isoleucine, leucine (Leu), phenyloalanine, lysine were evaluated.
Results: The level of His was significantly higher in both groups of migraine patients (without and with aura) compared to the control group (F(2,74)=10.17, p=0.00). The levels of Val and Leu were significantly different in migraine without but not with aura, when compared with the control group (F(2,74)=4.70, p=0.01 and F(2,74)=4.39, p=0.02, respectively).
Conclusion: We found higher level of His in migraine patients without and with aura and lower level of Val and Leu in patients with migraine without aura.
Export Options
About this article
Cite this article as:
Domitrz Izabela, Koter D. Marek, Cholojczyk Malgorzata, Domitrz Wojciech, Baranczyk-Kuzma Anna and Kaminska Anna, Changes in Serum Amino Acids in Migraine Patients without and with Aura and their Possible Usefulness in the Study of Migraine Pathogenesis, CNS & Neurological Disorders - Drug Targets 2015; 14 (3) . https://dx.doi.org/10.2174/1871527314666150225144300
DOI https://dx.doi.org/10.2174/1871527314666150225144300 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Thymoquinone Anticancer Discovery: Possible Mechanisms
Current Drug Discovery Technologies Chemistry and Pharmacology of Angiotensin-Converting Enzyme Inhibitors
Current Pharmaceutical Design Newer Insights in Personalized and Evidence Based Medicine- the Role of MicroRNAs
Current Pharmacogenomics and Personalized Medicine Antimicrobial Development in the Era of Emerging Resistance
Mini-Reviews in Medicinal Chemistry Novel Peptides: An Alternative Approach for the Treatment of Diabetes Mellitus
Current Drug Therapy Exploring the Management of Statin Intolerant Patients: 2016 and Beyond
Current Vascular Pharmacology Atypical Antipsychotics: Pharmacokinetics, Therapeutic Drug Monitoring and Pharmacological Interactions
Current Medicinal Chemistry Emerging Therapies for Diabetic Neuropathy: A Clinical Overview
Current Diabetes Reviews Novel and Emerging Drugs for Systemic Lupus Erythematosus: Mechanism of Action and Therapeutic Activity
Current Medicinal Chemistry Current Treatment of the Pulmonary Arterial Hypertension
Current Respiratory Medicine Reviews Spreading Depolarization Waves in Neurological Diseases: A Short Review about its Pathophysiology and Clinical Relevance
Current Neuropharmacology New Pharmacological Approaches Using Polyphenols on the Physiopathology of Neuropathic Pain
Current Drug Targets A Review of Lysergic Acid Diethylamide (LSD) in the Treatment of Addictions: Historical Perspectives and Future Prospects
Current Drug Abuse Reviews Treatment of Chronic Hepatitis C Virus Using Direct Acting Antivirals in Geriatric Egyptian Patients
Recent Advances in Anti-Infective Drug Discovery The Optimal Treatment of Thyroid Gland Function Disturbances During Pregnancy
Current Pharmaceutical Biotechnology New Insights into the Intracellular Mechanisms by Which PGI2 Analogues Elicit Vascular Relaxation: Cyclic AMP-Independent, Gs-Protein Mediated-Activation of MaxiK Channel
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Nature Against Depression
Current Medicinal Chemistry Supramolecular Chiro-Biomedical Aspect of β-Blockers in Drug Development
Current Drug Targets The Family B1 GPCR: Structural Aspects and Interaction with Accessory Proteins
Current Drug Targets <i>Dichrostachys cinerea</i>: Ethnomedicinal Uses, Phytochemistry and Pharmacological Activities - A Review
The Natural Products Journal